Rønningen K S, Undlien D E, Ploski R, Maouni N, Konrad R J, Jensen E, Hornes E, Reijonen H, Colonna M, Monos D S
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Eur J Immunol. 1993 May;23(5):1050-6. doi: 10.1002/eji.1830230511.
The TAP1 and TAP2 genes, located in the HLA class II region, encode subunits of a peptide transporter. Both genes display limited genetic variability; four different nucleotide substitutions have been found in the TAP2 gene. Here studies on linkage disequilibrium between TAP2 variants and HLA class II alleles are reported, in an attempt to evaluate whether TAP2 variants are associated with insulin-dependent diabetes mellitus (IDDM). As reported previously, a significant decrease of homozygosity for TAP2 alleles encoding alanine at residue 665 (665 Ala) and glutamine at 687 (687 Gln) paralleled by an increase in homozygosity for TAP2 alleles encoding threonine at residue 665 (665 Thr) and a stop codon at 687 (687 Stop), was found in both Finnish and Norwegian IDDM patients compared to random controls. However, a strong linkage disequilibrium between these TAP2 polymorphisms and given HLA-DR and -DQ genes was observed among healthy controls. The frequent 665 Thr and 687 Stop variants were in linkage disequilibrium both with the DR4-DQ8 and the DR3-DQ2 haplotypes, haplotypes which are strongly associated with IDDM. In contrast, the DR1-DQ5 and DR13-DQ6 (e.g. DQB1*0603) haplotypes, which are decreased among IDDM patients, were associated with the 665 Ala and 687 Gln variants. Thus, when DR- and DQ-matched patients and controls were compared, associations of the investigated TAP2 variants and IDDM were no longer detectable. These data, therefore, indicate that the associations previously found between certain TAP2 variants and IDDM are secondary to a primary association between this disease and particular DQ alpha beta heterodimers.
位于 HLA Ⅱ类区域的 TAP1 和 TAP2 基因编码一种肽转运体的亚基。这两个基因的遗传变异性有限;在 TAP2 基因中已发现四种不同的核苷酸替换。本文报道了关于 TAP2 变体与 HLA Ⅱ类等位基因之间连锁不平衡的研究,旨在评估 TAP2 变体是否与胰岛素依赖型糖尿病(IDDM)相关。如先前报道,与随机对照相比,在芬兰和挪威的 IDDM 患者中,编码 665 位丙氨酸(665 Ala)和 687 位谷氨酰胺(687 Gln)的 TAP2 等位基因纯合性显著降低,同时编码 665 位苏氨酸(665 Thr)和 687 位终止密码子(687 Stop)的 TAP2 等位基因纯合性增加。然而,在健康对照中观察到这些 TAP2 多态性与特定的 HLA-DR 和 -DQ 基因之间存在强烈的连锁不平衡。常见的 665 Thr 和 687 Stop 变体与 DR4-DQ8 和 DR3-DQ2 单倍型均处于连锁不平衡状态,而这两种单倍型与 IDDM 密切相关。相比之下,在 IDDM 患者中减少的 DR1-DQ5 和 DR13-DQ6(如 DQB1*0603)单倍型与 665 Ala 和 687 Gln 变体相关。因此,当比较 DR 和 DQ 匹配的患者与对照时,不再能检测到所研究的 TAP2 变体与 IDDM 之间的关联。所以,这些数据表明,先前发现的某些 TAP2 变体与 IDDM 之间的关联是该疾病与特定 DQαβ异二聚体之间主要关联的次要结果。